KLP Kapitalforvaltning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418M Buy
348,239
+30,360
+10% +$31M 1.35% 11
2026
Q1
$292M Buy
317,879
+9,600
+3% +$9.73M 1.15% 12
2025
Q4
$331M Buy
308,279
+3,560
+1% +$3.4M 1.28% 11
2025
Q3
$233M Buy
304,719
+700
+0.2% +$521K 0.92% 13
2025
Q2
$237M Buy
304,019
+10,000
+3% +$7.77M 1.02% 14
2025
Q1
$243M Buy
294,019
+5,100
+2% +$4.24M 1.19% 13
2024
Q4
$223M Buy
+288,919
New +$239M 1.06% 11

Other funds holding LLY

KLP Kapitalforvaltning's LLY Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Eli Lilly (LLY) stake by 9.6% in Q2 2026, buying an estimated $31M and bringing the position to 348,239 shares worth $418M. The position accounts for 1.35% of the portfolio, ranked #11.

KLP Kapitalforvaltning first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • KLP Kapitalforvaltning held 348,239 shares of Eli Lilly worth $418M as of Q2 2026.
  • KLP Kapitalforvaltning bought 30,360 Eli Lilly shares in Q2 2026, an estimated $31M.
  • Eli Lilly made up 1.35% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #11 holding.
  • KLP Kapitalforvaltning first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.